
President John Dramani Mahama has commissioned the Vaccine Research and Development (R&D) and Human Identification (DNA) laboratories at the Noguchi Memorial Institute for Medical Research (NMIMR) in Accra. These facilities represent a significant advancement in Ghana's medical infrastructure, aimed at achieving vaccine self-sufficiency and enhancing forensic investigation capabilities. The commissioning of the National Human Identification Laboratory specifically addresses a critical gap in local DNA analysis, which was previously outsourced to foreign laboratories. The establishment of the Human Identification Laboratory follows specific national challenges, notably the August 2025 military helicopter crash, which underscored the urgent need for rapid local DNA identification services. Equipped with advanced technology provided by ADB Ghana Medical Systems Group in collaboration with Thermo Fisher Scientific UK, the facility will now allow for timely identification of human remains and support various forensic investigations within the country. President Mahama noted that this advancement strengthens Ghana's public health and national security systems by providing local expertise for emergencies. Regarding the Vaccine R&D Laboratory, the President announced that Ghana is on track to produce its first locally manufactured vaccine—the tetanus-diphtheria vaccine—by early 2027. This initiative is supported by the National Vaccine Institute (NVI) and involves partnerships with the Africa CDC and the International Vaccine Institute. Currently, the government has already procured essential equipment and initiated training for scientists in mRNA technologies, using bulk substances sourced from Indonesia to begin the development process. President Mahama also highlighted the necessity of public participation in clinical trials to ensure the success and safety of locally developed vaccines. To further support the industry, the government is implementing the Ghana Pharmaceutical Manufacturing Policy, which includes tax exemptions on imported materials and the creation of a Ghana Biomanufacturing Training Consortium by the end of 2027. These measures are designed to create jobs, reduce the high cost of imported pharmaceuticals, and position Ghana as a hub for medical research in the West African sub-region.
myjoyonline.com
myjoyonline.com
myjoyonline.com
myjoyonline.com
Related topic
John Mahama: Latest News & Updates →